Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

LEMAITRE VASCULAR, INC.

(LMAT)
  Report
Real-time Estimate Cboe BZX  -  01:35:51 2023-01-27 pm EST
46.37 USD   +0.91%
2022LeMaitre to Present at Upcoming Investor Conferences
AQ
2022LEMAITRE VASCULAR, INC. : Ex-dividend day for
FA
2022LEMAITRE VASCULAR INC Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

LeMaitre Vascular, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022

10/27/2022 | 04:34pm EST

LeMaitre Vascular, Inc. reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was USD 39.03 million compared to USD 38.37 million a year ago. Net income was USD 5.46 million compared to USD 6.5 million a year ago. Basic earnings per share from continuing operations was USD 0.25 compared to USD 0.3 a year ago. Diluted earnings per share from continuing operations was USD 0.25 compared to USD 0.3 a year ago.
For the nine months, sales was USD 120.7 million compared to USD 114.92 million a year ago. Net income was USD 15.01 million compared to USD 20.73 million a year ago. Basic earnings per share from continuing operations was USD 0.68 compared to USD 0.99 a year ago. Diluted earnings per share from continuing operations was USD 0.68 compared to USD 0.98 a year ago.


ę S&P Capital IQ 2022
All news about LEMAITRE VASCULAR, INC.
2022LeMaitre to Present at Upcoming Investor Conferences
AQ
2022LEMAITRE VASCULAR, INC. : Ex-dividend day for
FA
2022LEMAITRE VASCULAR INC Management's Discussion and Analysis of Financial Condition and ..
AQ
2022Tranche Update on LeMaitre Vascular, Inc.'s Equity Buyback Plan announced on February 2..
CI
2022LeMaitre to Present at Upcoming Investor Conferences
AQ
2022North American Morning Briefing: Futures Pull -3-
DJ
2022Barrington Research Downgrades LeMaitre Vascular to Market Perform From Outperform
MT
2022Lemaitre : Q3 Earnings Snapshot
AQ
2022Transcript : LeMaitre Vascular, Inc., Q3 2022 Earnings Call, Oct 27, 2022
CI
2022LeMaitre Vascular, Inc. Reports Earnings Results for the Third Quarter and Nine Months ..
CI
More news
Analyst Recommendations on LEMAITRE VASCULAR, INC.
More recommendations
Financials (USD)
Sales 2022 162 M - -
Net income 2022 20,7 M - -
Net Debt 2022 - - -
P/E ratio 2022 49,4x
Yield 2022 1,09%
Capitalization 1 011 M 1 011 M -
Capi. / Sales 2022 6,24x
Capi. / Sales 2023 5,84x
Nbr of Employees 469
Free-Float 82,5%
Chart LEMAITRE VASCULAR, INC.
Duration : Period :
LeMaitre Vascular, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends LEMAITRE VASCULAR, INC.
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 8
Last Close Price 45,95 $
Average target price 58,83 $
Spread / Average Target 28,0%
EPS Revisions
Managers and Directors
George W. LeMaitre Chairman & Chief Executive Officer
David B. Roberts Chief Financial Officer
Joseph P. Pellegrino Chief Financial Officer, Secretary & Director
Jonathan W. Ngau Director-Information Technology
Ryan H. Connelly Vice President-Research & Development